Quality of weight loss during chemoradioherapy in patients with nasopharyngeal cancers

• Published in: Cancer radiothérapie 2023-06, Vol.27 (4), p.281-289
• Main Authors: Fourati, N., Trigui, R., Dhouib, F., Nouri, O., Siala, W., Khanfir, A., Mnejja, W., Daoud, J.
• Format: Article
• Language: English
• Subjects: Cancer; Nasopharyngeal; Nasopharynx; Poids; Radiotherapy; Radiothérapie; Weight
• ISSN: 1278-3218; 1769-6658
• DOI: 10.1016/j.canrad.2022.12.001

Radiation therapy with chemotherapy (CCR) is currently the gold standard treatment for nasopharyngeal carcinoma (NPC). Anatomical changes are mainly due to weight loss. Our prospective study aimed to evaluate the nutritional status and the quality of weight loss in our patients to adapt the subsequent nutritional management of patients during treatment for NPC. A prospective, single-center study of 27 patients with non-metastatic NPC treated in our oncology radiotherapy department between August 2020 and March 2021. Data from interrogation, physical examination, and bioelectrical impedancemetry (weight [W], body mass index [BMI], fat index [GI], fat mass [FM], and fat-free mass (FFM]) were collected at the beginning, the mid, and the end of treatment. Weight loss from mid to end of treatment (median=−4kg [−9.4; −0.9]) was greater than that from baseline to mid-treatment (median=−2.9kg [−8.8; 1.8]) (P=0.016). Weight loss during the entire treatment was −6.2kg [−15.6; −2.5] (8.4%). The losses of FM were identical between the beginning-mid treatment and the mid-end treatment; they were respectively −1.4kg [−8.5; 4.2] and −1.4kg [−8.2; 7.8] (P=0.4). FFM losses between the mid- and the end of treatment (−2.5kg [−27.8; 0.5]) were greater than those between baseline and mid-treatment (−1.1kg [−7.1; 4.7]) (P=0.014). Median FFM loss during treatment was −3.6kg [−28.1; 2.6]). The results of our study show that weight loss during CCR for NPC is complex and is not just about loss but about a disruption of body composition. Regular follow-ups by nutritionists are required to prevent denutrition during treatment. La radiothérapie associée à la chimiothérapie est le traitement de référence du carcinome nasopharyngé. Les modifications anatomiques sont principalement dues à la perte de poids. L’objectif de notre étude prospective était d’évaluer l’état nutritionnel et la qualité de la perte de poids de nos patients afin d’adapter la prise en charge patients lors du traitement du carcinome nasopharyngé. Étude prospective, monocentrique de 27 patients atteints de carcinome nasopharyngé non métastatique traités dans notre service de radiothérapie oncologique entre août 2020 et mars 2021. Les données de l’interrogatoire, de l’examen physique et de l’impédancemétrie bioélectrique (poids [W], indice de masse corporelle [IMC], indice de graisse [GI], masse grasse [FM] et masse sans graisse [FFM]) ont été recueillies au début, au milieu et à la fin du traitement. La perte de poids